Novozymes maintains its 2018 expectations for organic sales growth of 4-6 percent, announces the firm Wednesday morning CET in the Q1 interim report.
The EBIT margin is expected to be around 28 percent, while the bottom line is expected to land around the 2017 level of DKK 3,120 million (EUR 419 million).
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for EnergyWatch has now started
With your free trial you get:
Full access to all locked articles on EnergyWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.
More from EnergyWatch
The cybercriminal group that has held Vestas' internal data hostage over the past two weeks is known by the Danish Defence Intelligence Service. Several reports provide insight on recruitment and targets of "Lockbit 2.0" – also establishing possible connection to last year's major hacker attack on the US' Colonial Pipeline.